# Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

> **NCT03680612** · PHASE2 · COMPLETED · sponsor: **Allecra** · enrollment: 45 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Cefepime 1G - 2G / AAI101 0.5G - 0.75G
- **DRUG:** cefepime 1 g or cefepime 2 g

## Key facts

- **NCT ID:** NCT03680612
- **Lead sponsor:** Allecra
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-05
- **Primary completion:** 2018-02-14
- **Final completion:** 2018-02-14
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680612, "Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03680612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*